InnovationRx is a weekly digest of healthcare news. To receive it in your inbox, Subscribe here.
getty
TThere is no central clearinghouse here to regulate algorithms used in medicine. Certain commercial applications, such as the Apple Watch heart rate monitor, have been approved by the Food and Drug Administration. However, algorithms developed by electronic health records companies such as Epic and Oracle Cerner fall under the purview of the National Coordinator for Health IT (ONC).
“We’re not regulating AI-enabled tools themselves,” ONC Director Mickey Tripati said. forbes Rather, he likens the approach to a “nutrition label” on a food package, referring to the new rules that his agency recently finalized and will go into effect on March 11, 2024. Electronic health record companies are required to document 33 different data elements, including: For hospital and physician customers, this includes information about what data the model is trained on and how it works. In technical terminology, these labels are often referred to as model cards. “We don’t really think about, ‘Is this a good product or is this a bad product?'” Tripathi says. “We’re just saying we should provide information to customers so they can make their own decisions. But it applies to a much broader range of products than the FDA regulations.”
The rule only applies to tools developed by electronic health record companies, but Tripathi wants other app developers and in-house health system building tools to also include nutrition labels. “We actually believe that blank fields provide information,” he said, adding that if developers refuse to provide information on topics such as health equity, safety, and performance bias, customers may said people should be cautious about using the tool. “We’re not trying to dictate how they do this, but we’re saying they should have a formal and thoughtful process for how they incorporate algorithms into their products. ”
This $674 million deal aims to transform the body’s waste disposal into a disease-fighting tool
Vantieri
VantAI just announced a deal with Bristol-Myers Squibb Company worth up to $674 million. the goal? Using generative AI to design so-called “molecular glue.” These glues bind to pathogens in the body, such as cancer cells, and connect them to proteolytic agents that the cells use to break down what they no longer need.
Why AI? VantAI CEO Zach Carpenter explained that the human body does not naturally use this process to fight disease. forbes. “You can’t find the glue just by trial and error.” Molecules need to be designed to do it, which would be a daunting task without the advances in machine learning of the past decade.
Please see here for the detail.
Pipeline and deal updates
Liver disease: Gilead will acquire CymaBay, which is developing a potential treatment for the liver disease primary biliary cholangitis, in a deal valued at approximately $4.3 billion.
Non-opioid pain: Biotech startup Latigo Biotherapeutics has emerged from stealth with a $135 million Series A round led by Westlake Village BioPartners. The company aims to develop non-opioid treatments for pain.
Digestive system: The FDA has approved Takeda Pharmaceutical’s Eohilia, an oral treatment for eosinophilic esophagitis. This condition is caused by inflammation of the esophagus and can cause choking and other swallowing problems.
Metabolic diseases: BioAge, which develops treatments aimed at tackling obesity and metabolic diseases, announced it has raised $170 million in a Series D round led by Sofinnova Investment.
frostbite: The FDA has approved iloprost, sold by Eicos Science as Aurlumyn, to treat severe frostbite. This is the first such approval, and in clinical trials, its application prevented patients from having to have toes or fingers amputated.
Meet the Brian Johnson-approved AI whole-body MRI startup that raised $21 million
brian johnson
Brian Johnson is the self-proclaimed “most thoughtful man in human history.” He’s the new figurehead for an old Silicon Valley frenzy: “biohacking” your body to extend your lifespan. His “gold standard” body measurement tool? This is a whole body MRI test. Johnson told Forbes he expects to win six this month alone.
One of his go-to providers is Ezra, a New York-based startup that uses artificial intelligence to speed up processes. With $21 million in new funding, Ezra co-founder and CEO Emi Gall, a biohacker and longevity enthusiast herself, wants to bring these MRIs to the mainstream. thinking. But medical experts say full-body MRI scans may do more harm than good for the majority of patients, potentially exposing people who are not at particular risk for cancer or another disease to overtreatment or overdiagnosis. I am concerned that there is a gender.
Please see here for the detail.
Other healthcare news
of european union approved on Tuesday Kasjivithe world’s first drug based on CRISPR gene editing technology to treat two blood diseases, following US and UK
CVS Health CEO Karen Lynch The healthcare giant said its rivals are sticking to plans to open 50 to 60 clinics for seniors next year. walgreens Clinic expansion withdrawn.
of CDC plans to suspend its five-day quarantine guidelines for the coronavirus.
Secretary of Defense Lloyd Austin This is his second hospitalization this year, and his duties have been transferred to his deputy.
Patients in rural areas face an even tougher situation EMS New research shows there are more sirens than in urban and suburban areas, so people should be careful.
beyond forbes
Dreaming California: How 90 acres of oceanfront land in Huntington Beach could afford America’s greenest oil
AI found him a date. ChatGPT asked him to propose. Now they are married.
50 hottest fintech startups
what else are you reading
One year later, the U.S. still isn’t taking advantage of Humira’s low-cost biosimilar (statistics)
The future of precision cancer treatment may be about trying everything (Nature)
Does delayed intake of Rekenbi pose a risk to Biogen’s recovery? (Endpoint)
